The role of AURKA inhibitor in the treatment of HCC still needs more studies, including exploring more combined treatment methods and screening potential benefit patient groups, which will speed up the clinical promotion of alisertib in the treatment of HCC, and also provide more treatment options for advanced HCC. Here, AURKA is linked to hepatocellular carcinoma.